This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: University of Pennsylvania. Active years: 2011-2012.
Location History:
- Brighton, MA (US) (2011)
- Boston, MA (US) (2012)
Company Filing History:
Years Active: 2011-2012
Title: Innovations of Andrew Y Choo
Introduction
Andrew Y Choo is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of immunotherapeutics and vaccines. With a total of 2 patents, his work has the potential to impact medical treatments and immunology.
Latest Patents
Andrew Y Choo's latest patents include innovative methods and compositions related to nucleic acid sequences. One of his patents focuses on nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15, along with methods for their use. This patent discloses fusion proteins and nucleic acid molecules encoding these proteins, which include non-IL-15 signal peptides linked to IL-15 protein sequences. Additionally, it covers vectors and host cells that comprise such nucleic acid molecules, as well as recombinant vaccines and live attenuated pathogens encoding these fusion proteins. Another patent details the immunomodulatory effects following the delivery of IL-15 and CD40L, with or without immunogens, and various nucleic acid molecules used for delivering these proteins.
Career Highlights
Andrew Y Choo is affiliated with the University of Pennsylvania, where he continues to advance his research in immunology and biotechnology. His work has garnered attention for its potential applications in developing new vaccines and therapeutic methods.
Collaborations
Some of his notable coworkers include Michele Kutzler and David B Weiner, who have collaborated with him on various research projects.
Conclusion
Andrew Y Choo's contributions to biotechnology and immunology through his patents and research at the University of Pennsylvania highlight his role as an influential inventor in the field. His innovative approaches to vaccine development and immunotherapeutics are paving the way for future advancements in medical science.